suPAR at Congresses & Conferences
The ViroGates team visits a variety of scientific and commercial congresses every year.For 2011 the following events are planned:
2011:
November 16-19, Dusseldorf, Germany
MEDICA - World Forum for Medicine (www.medica-tradefair.com)
Jakob Knudsen, CEO, and Claus Berner, VP Sales & Marketing, will be present at Medica to discuss business opportunities.
November 12-16, Antalya, Turkey
1st National Clinical Microbiology Congress
suPARnostic® presented by Hemakim Medical Products (www.hemakim.com.tr) at the congress – please visit the stand and get introduction to suPARnostic®.
November 2-4, Rome, Italy
National Congress of the Academy of Emergency Medicine and Care (AcEMC)
“Good clinical practice and scientific research in emergency medicine".
Presentation on Nov. 2, 11.35-12.35:
"Use of biomarker suPAR in the prognostic evaluation of sepsis".
Oral presentations by Dr. Jesper Eugen Olsen, Laboratory Research Director, Hvidovre Hospital, Denmark (suPAR - The future risk biomarker in sepsis), Ivo Casagranda (Preliminary results from the multicentric study) and Carlo Arfini (suPAR seen from a Lab Manager point of view).
October 26-28, Beijing, China
Sepsis 2011 (www.sepsisforum.org/sepsisconferences)
Jakob Knudsen, CEO, will be present at the conference to discuss business opportunities.
October 25-28, Munich, Germany
Medical Biodefense Conference 2011 (www.biodefense2011.org)
Claus Berner, VP Sales & Marketing will be present on Oct. 26 to discuss business opportunities.
October 1-5, Berlin, Germany
24´th ESICM LIVES 2011 - Annual Congress of the European Society of Intensive Care Medicine (www.esicm.org)
Oral presentation of abstract by Dr Katia Donadello, Erasme Hospital, Brussels, Belgium on Oct. 4 at 15.25-15.40 in Stockholm room:
"Clinical Value of suPAR, a new biomarker"See Presentation Abstract here.
Jakob Knudsen, CEO, and Henrik Tommerup, VP Business Development, will be present at the congress Oct. 3-4 to discuss business opportunities.
September 28-29, Vienna, Austria
9´th Planet xMAP Europe, 2011 (www.planetxmap.com)
Henrik Tommerup, VP Business Development, ViroGates, will be present to discuss business opportunities.
July 24-28, Atlanta, Georgia, USA
2011 AACC Annual Meeting - American Association for Clinical Chemistry (www.aacc.org/events)
Henrik Tommerup, VP Business Development, ViroGates, will be present to discuss business opportunities.
May 25-26, Sibiu, Romania
2011 RSLM - 18´th National Congress of Laboratory Medicine (www.srlmcongres.ro/EN)
Oral presentation by Ch. Cristina Hristodorescu, General Manager, Praxis Medica, on May 26:
"Diagnosing patient criticality: Patient prognosis with suPARnostic®"
May 7-10, Milan, Italy
21’st ECCMID - European Congress of Clinical Microbiology and Infectious Diseases (www.eccmid-icc2011.org)
Presentation of abstract "Predictive value of soluble urokinase plasminogen activator factor in ventilator-associated pneumonia and sepsis".
See Presentation Abstract here.
Henrik Tommerup, VP Business Development, ViroGates, will be present to discuss business opportunities.
April 28-29, Manchester, United Kingdom
8´th Annual Critical Care Symposium (www.critcaresymposium.co.uk)
Henrik Tommerup, VP Business Development, ViroGates, will be present.
April 6-9, Madrid, Spain
4’th International Congress on Prediabetes and the Metabolic Syndrome (www.kenes.com/prediabetes)
Oral presentation of abstract by Dr. Steen B. Haugaard, Hvidovre Hospital, Copenhagen, Denmark:
"The immunue marker soluble urokinase plasminogen activator receptor is associated with new-onset diabetes in non-smoking women and men"
Henrik Tommerup, VP Business Development, ViroGates, will also be present at the congress.
March 22-25, Brussels, Belgium
31´st ISICEM - International Symposium on Intensive Care and Emergency Medicine (www.intensive.org)
Four oral presentations on suPAR will take place:
"The Value of suPAR" by Georgios Dimopoulos (Athens, Greece)
"suPAR in sepsis" by Katia Donadello (Erasme Hospital, Brussels, Belgium)
"suPAR"by Frank Tacke (University Hospital Aachen, Germany)
"Towards better stratification?" by Evangelos Giamarellos-Bourboulis (Attikon Hospital, Athens, Greece)
For more information please see 
suPAR at ISICEM
Henrik Tommerup, VP Business Development, Claus Berner, VP Sales & Marketing, and Louise Hebert, Product Manager, will be present at the Symposium.
March 17, Geneva, Switzerland
Healthcare in Europe
(http://eu.economistconferences.com/event/european-healthcare-summit)
Transforming Europe´s healthcare systems - where should change happen?
Henrik Tommerup, VP Business Development, ViroGates, will be present.
March 7-8, Copenhagen, Denmark
2´nd International suPAR Symposium (www.conferencemanager.dk/suPAR2011)
"Discussion of the features and potential usability of the suPAR protein as a biomarker"
Hosted by Hvidovre University Hospital, Copenhagen, Denmark and sponsored by ViroGates. Henrik Tommerup, VP Business Development, Claus Berner, VP Sales & Marketing, and Louise Hebert, Product Manager, is looking forward to meeting you.
February 24-26, Porto, Portugal
16th International Symposium on infections in the critically ill patient
(www.infections-online.com)
Claus Berner, VP Sales & Marketing, ViroGates, will be present at the Symposium.
January 13-15, Krakow, Poland
Collegium Medicine Laboratory meeting
Two oral presentations about suPAR in session IN VITRO PROGNOSTIC by Prof. Kulpa and Prof. Paradowski.
Louise Hebert, Product Manager, ViroGates will also be present.
2010:
November 17-18, Düsseldorf, Germany
MEDICA - World Forum for Medicine (www.medica-tradefair.com)
Henrik Tommerup, VP Business Development, Claus Berner, VP Sales & Marketing, and Louise Hebert, Product Manager, will be present at Medica to discuss business opportunities. For more information and appointment, please contact Claus Berner, tel. no. + 45 4085 3162 or at
This e-mail address is being protected from spambots. You need JavaScript enabled to view it
November 11-12, Jyväskylä, Finland
Chemestri Lab Society Meeting, SKKY
Oral presentation by Dr. Jesper Eugen Olsen, Laboratory Research Director, Clinical Research Centre, Hvidovre Hospital, Copenhagen, Denmark.
Louise Hebert, Product Manager, ViroGates will also be present.
October 29-30, Chennai, India
The International Critical Care Symposium, ICCS 2010 (www.iccs2010.com)
Henrik Tommerup, VP Business Development, ViroGates A/S, will be present at the symposium.
October 20-21, Vienna, Austria
Planet xMAP Europe 2010 (www.planetxmap.com)
Henrik Tommerup, VP Business Development, ViroGates A/S, will be present at the congress.
October 15, Stockholm, Sweden
Seminar at Karolinska Hospital
Oral presentation by Henrik Tommerup, VP Business Development, ViroGates A/S on suPAR:
"suPAR inflammatory biomarker: independent and strong prognosis"
October 9-13, Barcelona, Spain
23rd Annual Congress of the European Society of Intensive Care Medicine, ESICM (www.esicm.org)
Henrik Tommerup, VP Business Development and Louise Hebert, Product Manager, will be present at the congress.
September 12-15, Boston, USA
50th ICAAC (Interscience Conference on Antimicrobial Agents and Chemotherapy) (www.icaac.org)
Dr. Koksal from Turkey will present her studies; "The Diagnostic and Prognostic Significance of suPAR in Systemic Inflammatory Response Syndrome"
(see Presentation Abstract here)
September 1-3, Paris, France
Sepsis 2010 (www.sepsisconference.com)
Henrik Tommerup, VP Business Development, Claus Berner, VP Sales & Marketing, and Louise Hebert, Product Manager, will be present at the conference.
June 17-18, Ksiaz, Poland
1'st International Sepsis Conference "Surviving Sepsis" (www.anest.am.wroc.pl)
Oral presentation by Henrik Tommerup, VP Business Development and Louise Hebert, Product Manager, ViroGates A/S:
"Diagnosing patient criticality: Patient prognosis with suPARnostic®"
June 14-16, Tel-Aviv, Israel
ILSI-BioMed 2010 Conference (www.kenes.com/biomed)
Henrik Tommerup, VP Business Development, ViroGates A/S will be present at the conference to discuss business opportunities, and also on June 13 at the ILSI-Cleveland Seminar "From Idea to Bench to Bedside, A Biomedical Innovation Summit" (http://www2.kenes.com/biomed/ilsi/Pages/ILSI-Cleveland_seminar.aspx)
June 8-11, Copenhagen, Denmark
41'st Nordic Gastroenterology Congress (www.ngc2010.com)
suPARnostic® presented by Electra-Box, Denmark (www.electrabox.com)
May 27-28, Athens, Greece
4'th European Conference on Bloodstream Infections (www.sepsis.gr)
Henrik Tommerup, VP Business Development, ViroGates A/S, will be present at the conference, which is also the venue for meeting the Hellenic Sepsis Study Group.
April 20 - 22, Stockholm, Sweden
Spring meeting Clinical Chemistry 2010 (www.kemivarmote2010.se)
Oral presentation by Henrik Tommerup, VP Business Development, ViroGates A/S on April 20:
"Who lives and who will die - patient prognosis with suPARnostic®"suPARnostic® presented by Electra-Box Diagnostica AB (www.electrabox.com) at the meeting – please visit the stand and get introduction to suPARnostic®.
April 10-13, Vienna, Austria
20’th ECCMID (European Congress of Clinical Microbiology and Infectious Diseases) (www.congrex.ch/ECCMID2010)
Representatives from ViroGates will be present at ECCMID to discuss business opportunities. For more information and appointment, please contact Product Manager Louise Hebert. Tel. No. + 45 2097 1363 or at
This e-mail address is being protected from spambots. You need JavaScript enabled to view it
March 25, Brussels, Belgium
Seminar at Erasme Hospital, hosted by Prof. Jean-Louis Vincent, Head Dept. of Intensive Care.
Oral presentation by Dr. Jesper Eugen Olsen, Laboratory Research Director, Clinical Research Centre, Hvidovre Hospital, Copenhagen, Denmark:
"Inflammation biomarker suPARnostic®: Prognostic value in assessment of disease severity in SIRS/sepsis patients"
Henrik Tommerup, VP Business Development, ViroGates A/S, will also be present.
February 10-14, Hyderabad, India
International Critical Care Congress & 16th Annual Conference of Indian Society of Critical Care Medicine (www.criticare2010.com)
Henrik Tommerup, VP Business Development, ViroGates A/S, will be present at the congress.
